Arkis BioSciences

About:

Arkis BioSciences® is a medical device company providing advanced implantable technology and minimally invasive surgical instrumentation.

Website: https://www.arkisbiosciences.com

Top Investors: Innova Memphis, Lighthouse Funds, Angel Capital Group

Description:

Arkis BioSciences develops, markets, and sells advanced catheters and minimally invasive instrumentation for neurosurgery. Arkis' proprietary catheters incorporate Endexo, intended to reduce catheter related complications, while the company's instrumentation is designed to be less invasive over a variety of neurosurgical procedures. Altogether, the company's portfolio enables healthcare practitioners the potential to reduce surgical trauma, shorten surgical duration, and reduce treatment complications.

Total Funding Amount:

$9.63M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Knoxville, Tennessee, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)arkisbiosciences.com

Founders:

Chad Seaver, Chris Arnott, James Killeffer, M.D.

Number of Employees:

11-50

Last Funding Date:

2019-02-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai